The fast-growing company will anchor 399 Binney St., an Alexandria Real Estate Equities property.
For the second time in less than a year, cancer drug startup Rubius Therapeutics is more than doubling its footprint in Cambridge. And this time, the company is set to anchor a major new development in Kendall Square.
The fast-growing company will anchor 399 Binney St., an Alexandria Real Estate Equities property that is expected to be completed by the end of the year.
